GLUTAMINYL CYCLASE AS A DIAGNOSTIC / PROGNOSTIC INDICATOR FOR NEURODEGENERATIVE DISEASES

摘要

GLUTAMINYL CYCLASE AS A DIAGNOSTIC / PROGNOSTIC INDICATOR FOR NEURODEGENERATIVE DISEASESThe present invention relates to a method for predicting, diagnosing and prognosticating a neurodegenerative disease, such as Alzheimer's disease (AD), Mild Cognitive Impairment (MCI) and neurodegeneration in Down's syndrome (NDS) using glutaminyl cyclase (QC) as a diagnostic/prognostic indicator. The use of antibodies binding to QC and kits for performing said diagnostic method are also provided.No Figure.